Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
Provided By PR Newswire
Last update: Aug 16, 2024
Broadens Lilly's immunology pipeline with Morphic's oral integrin therapies, including MORF-057
Reinforces the company's strategy of delivering potential first or best-in-class therapies in the field of gastroenterology
Read more at prnewswire.com779.28
+3.38 (+0.44%)
Find more stocks in the Stock Screener
LLY Latest News and Analysis
8 days ago - ChartmillWhich S&P500 stocks are moving on Wednesday?Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.
13 days ago - ChartmillUncover the latest developments among S&P500 stocks in today's session.Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
13 days ago - ChartmillStay informed with the top movers within the S&P500 index on Friday.Curious about the top performers within the S&P500 index in the middle of the day on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
13 days ago - ChartmillFriday's session: gap up and gap down stock in the S&P500 indexWondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Friday to uncover the stocks that are gapping in the S&P500 index.
15 days ago - ChartmillMarket Monitor News June 18 (Jabil, Reddit & Verve Therapeutics UP - Solar Stocks First Solar, Sunrun & SolarEdge DOWN)Wall Street stays cool despite geopolitical tension, weak retail data, and a meltdown in solar stocks.
